# The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans

> **NCT06972407** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Mayo Clinic** · enrollment: 80 (estimated)

## Conditions studied

- Genetic Predisposition
- Type2diabetes

## Interventions

- **BIOLOGICAL:** Exendin 9-39
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT06972407
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-03-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06972407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06972407, "The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06972407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*